Riskpilot← Back to searchSign inGet full accessMedoptic Oy
OYDissolvedY-tunnus 0825678-0Unioninkatu 45-B27Medical specialists activities · NACE 8622Est. 19901 employees
Revenue 2025
EUR 0
EBITDA margin
—
-5578% vs 2024
Equity ratio
97.9%
Financial strength
Net profit 2025
EUR -24
-106% vs 2024
| Revenue | EUR 0 | — |
| EBITDA | EUR -22K | -5578% |
| Net profit | EUR -24 | -106% |
| Total assets | EUR 407K | -9% |
| Equity | EUR 398K | -9% |
| Employees | 1 | — |
Legal name
Medoptic Oy
Y-tunnus number
0825678-0
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
11. joulukuuta 1990
Share capital
EUR 8 409
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön toimialana on silmälääkäritoimen harjoittaminen. Yhtiö voi omistaa, hallita ja vuokrata kiinteätä omaisuutta sekä kiinteistö- ja asunto-osakeyhtiöiden osakkeita. Yhtiö voi myös harjoittaa arvopaperikauppaa.
Address
Unioninkatu 45-B27
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 90 | 82 | 100 | 39 | 0 |
| Staff expenses | −32 | −34 | −38 | −19 | −12 |
| EBITDA | 30 | 20 | 13 | −0 | −22 |
| Depreciation & amort. | −1 | −0 | −0 | −0 | −1 |
| EBIT | 29 | 19 | 12 | −1 | −22 |
| Net financials | 2 | 16 | −4 | 1 | 22 |
| Profit before tax | 32 | 35 | 8 | 1 | −0 |
| Tax | 6 | 7 | 2 | 0 | −0 |
| Net profit | 26 | 28 | 6 | 0 | −0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 537 | 523 | 486 | 445 | 407 |
| Equity | 528 | 513 | 477 | 436 | 398 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 9 | 11 | 9 | 852 | 8 |
| Total debt | 9 | 11 | 9 | 9 | 8 |
EBITDA margin
-2157800.0%
This company
15.8%
Market median
-13657062% vs market
20212025
Equity ratio
97.9%
This company
38.2%
Market median
+156% vs market
20212025
Return on equity
-0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
-2400.0%
This company
8.1%
Market median
-29730% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PH Deputy Member | Deputy Member | 2019 |
RK Chief Executive Officer | Chief Executive Officer | 1998 |
| Former (4) | ||
KM Audit | Audit | 2012 – 2019 |
VA | Audit | 2020 – 2023 |
RO Deputy Member | Deputy Member | 2012 – 2019 |
| Audit | 2019 – 2020 | |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medoptic Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Katja Maria Pesonen | Audit | 0 companies |
| Pauliina Hilma Annikki Meskanen | Deputy Member | 0 companies |
| Ritva Kyllikki Räty | Chief Executive Officer | 0 companies |
| Virpi Anneli Hurskainen | Audit | 0 companies |
| Reijo Olavi Räty | Deputy Member | 0 companies |
| Mikko Paavo Johannes Susitaival | Audit | 0 companies |